A new oral phosphodiesterase-5 inhibitor Indicated for the treatment of ED

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2012年 / 47卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：250 / 251
页数：2
相关论文
共 50 条
  • [1] Development of polymyositis after taking tadalafil, an oral phosphodiesterase-5 inhibitor
    Thompson, B.
    Pratt, A.
    Griffiths, B.
    RHEUMATOLOGY, 2007, 46 : I72 - I72
  • [2] Effect of phosphodiesterase-5 inhibitor on hearing
    Okuyucu, S.
    Guven, O. E.
    Akoglu, E.
    Ucar, E.
    Dagli, S.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2009, 123 (07): : 718 - 722
  • [3] Vardenafil: a selective inhibitor of phosphodiesterase-5 for the treatment of erectile dysfunction
    Reffelmann, Thorsten
    Kloner, Robert A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (07) : 965 - 974
  • [4] TESTOSTERONE LEVEL PREDICTS OUTCOME OF PHOSPHODIESTERASE-5 INHIBITOR TREATMENT
    Ho, C.
    Akhavanmalyeri, A.
    Jasman, M. H.
    Tan, G. H.
    Singam, P.
    Goh, E. H.
    Bahadzor, B.
    Zainuddin, Md Z.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 236 - 236
  • [5] Treatment of Raynaud's phenomenon with tadalafil, a phosphodiesterase-5 inhibitor
    Carlino, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 258 - 258
  • [6] Oral phosphodiesterase-5 inhibitors and sperm functions
    T Mostafa
    International Journal of Impotence Research, 2008, 20 : 530 - 536
  • [7] Oral phosphodiesterase-5 inhibitors and sperm functions
    Mostafa, T.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2008, 20 (06) : 530 - 536
  • [8] Long-term oral phosphodiesterase-5 inhibitor therapy alleviates recurrent priapism
    Burnett, AL
    Bivalacqua, TJ
    Champion, HC
    Musicki, B
    JOURNAL OF UROLOGY, 2006, 175 (04): : 301 - 301
  • [9] EFFECTS OF PHOSPHODIESTERASE-5 INHIBITOR TADALAFIL ON TRANSIENT CEREBRAL ISCHEMIA IN GERBILS: IMPLICATIONS FOR A NEW TREATMENT STRATEGY
    Park, H. J.
    Lee, H. S.
    Cho, Y. S.
    Joo, K. J.
    Kwon, C. H.
    Kim, K. H.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 267 - 267
  • [10] Identification of benzamidenafil, a new class of phosphodiesterase-5 inhibitor, as an adulterant in a dietary supplement
    Zou, Peng
    Hou, Peiling
    Oh, Sharon Sze-Yin
    Ge, Xiaowei
    Bloodworth, Bosco Chen
    Low, Min-Yong
    Koh, Hwee-Ling
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 47 (02) : 255 - 259
12345